In addition to the amplification of the CDK8 (cyclin dependent kinase-8) gene, which is situated at 13q12.13 and is present in around sixty percent of cases of colorectal cancer, there are other genetic perturbations that have the ability to alter the activity of β-Catenin. Here, CDK8 is linked to colorectal cancer.